Rein Therapeutics (RNTX) Competitors $1.40 -0.10 (-6.67%) As of 07/15/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesSEC FilingsTrendsBuy This Stock RNTX vs. GNLX, NKTX, KRRO, FTLF, SKYE, ACTU, ATOS, TARA, BHST, and CRDLShould you be buying Rein Therapeutics stock or one of its competitors? The main competitors of Rein Therapeutics include Genelux (GNLX), Nkarta (NKTX), Korro Bio (KRRO), FitLife Brands (FTLF), Skye Bioscience (SKYE), Actuate Therapeutics (ACTU), Atossa Genetics (ATOS), Protara Therapeutics (TARA), BioHarvest Sciences (BHST), and Cardiol Therapeutics (CRDL). These companies are all part of the "pharmaceutical products" industry. Rein Therapeutics vs. Its Competitors Genelux Nkarta Korro Bio FitLife Brands Skye Bioscience Actuate Therapeutics Atossa Genetics Protara Therapeutics BioHarvest Sciences Cardiol Therapeutics Genelux (NASDAQ:GNLX) and Rein Therapeutics (NASDAQ:RNTX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, media sentiment, valuation, risk, dividends and analyst recommendations. Is GNLX or RNTX more profitable? Rein Therapeutics' return on equity of -86.07% beat Genelux's return on equity.Company Net Margins Return on Equity Return on Assets GeneluxN/A -93.04% -74.17% Rein Therapeutics N/A -86.07%-31.11% Do institutionals and insiders hold more shares of GNLX or RNTX? 37.3% of Genelux shares are owned by institutional investors. Comparatively, 90.9% of Rein Therapeutics shares are owned by institutional investors. 9.3% of Genelux shares are owned by company insiders. Comparatively, 5.1% of Rein Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger valuation and earnings, GNLX or RNTX? Genelux has higher revenue and earnings than Rein Therapeutics. Genelux is trading at a lower price-to-earnings ratio than Rein Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGenelux$10K11,630.08-$29.87M-$0.88-3.50Rein TherapeuticsN/AN/A-$62.88M-$2.86-0.49 Does the media favor GNLX or RNTX? In the previous week, Genelux had 2 more articles in the media than Rein Therapeutics. MarketBeat recorded 3 mentions for Genelux and 1 mentions for Rein Therapeutics. Rein Therapeutics' average media sentiment score of 1.87 beat Genelux's score of 0.63 indicating that Rein Therapeutics is being referred to more favorably in the news media. Company Overall Sentiment Genelux Positive Rein Therapeutics Very Positive Do analysts recommend GNLX or RNTX? Genelux currently has a consensus price target of $17.75, suggesting a potential upside of 476.30%. Given Genelux's stronger consensus rating and higher possible upside, research analysts plainly believe Genelux is more favorable than Rein Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Genelux 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20Rein Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more volatility and risk, GNLX or RNTX? Genelux has a beta of -0.34, suggesting that its share price is 134% less volatile than the S&P 500. Comparatively, Rein Therapeutics has a beta of 1.22, suggesting that its share price is 22% more volatile than the S&P 500. SummaryGenelux beats Rein Therapeutics on 9 of the 15 factors compared between the two stocks. Get Rein Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for RNTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RNTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RNTX vs. The Competition Export to ExcelMetricRein TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$33.23M$2.96B$5.61B$9.29BDividend YieldN/A2.43%4.23%4.03%P/E Ratio-0.4920.2228.5419.58Price / SalesN/A299.17429.2495.01Price / Cash3.3543.1536.0257.93Price / Book3.267.568.145.54Net Income-$62.88M-$55.11M$3.24B$257.73M7 Day Performance-6.04%3.81%0.18%-0.08%1 Month Performance-23.08%11.60%5.96%8.09%1 Year PerformanceN/A-2.11%26.24%13.02% Rein Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RNTXRein TherapeuticsN/A$1.40-6.7%N/AN/A$33.23MN/A-0.499GNLXGenelux1.2006 of 5 stars$3.43-0.3%$17.75+417.5%+17.6%$129.81M$10K-3.9010NKTXNkarta1.8124 of 5 stars$1.83+1.7%$14.33+683.2%-74.1%$127.72MN/A-1.21140Positive NewsKRROKorro Bio1.5181 of 5 stars$12.71-6.5%$102.43+705.9%-74.3%$127.62M$2.27M-1.3570FTLFFitLife Brands4.0475 of 5 stars$13.02-1.3%$20.50+57.5%-19.3%$123.87M$64.47M15.5020SKYESkye Bioscience2.1358 of 5 stars$3.98+1.0%$16.60+317.1%-40.6%$122.04MN/A-4.8511ACTUActuate Therapeutics2.7248 of 5 stars$6.14-0.6%$20.50+233.9%N/A$121.25MN/A0.0010Positive NewsATOSAtossa Genetics3.1457 of 5 stars$0.94+5.7%$6.17+557.1%-34.7%$121.23MN/A-4.478Positive NewsTARAProtara Therapeutics2.1423 of 5 stars$3.05-2.2%$20.50+572.1%+28.2%$120.38MN/A-1.7730BHSTBioHarvest SciencesN/A$7.18-0.6%$13.67+90.3%N/A$118.59M$25.19M-14.36N/ACRDLCardiol Therapeutics2.4275 of 5 stars$1.29-5.8%$8.00+520.2%-39.4%$113.23MN/A-3.7920Gap Up Related Companies and Tools Related Companies GNLX Competitors NKTX Competitors KRRO Competitors FTLF Competitors SKYE Competitors ACTU Competitors ATOS Competitors TARA Competitors BHST Competitors CRDL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RNTX) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rein Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rein Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RNTX Stock Alerts